New Recruiting Trial: A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
WHY IT MATTERS
This trial offers prostate cancer patients on androgen deprivation therapy a potential new way to objectively track vasomotor symptoms they experience, which could lead to better symptom management and treatment decisions.
Researchers are testing whether smartwatches can help track hot flashes and other heat-related symptoms in men with prostate cancer who are receiving hormone therapy. The study will measure body temperature, heart rate, and skin changes using wearable technology to see if this is a practical way to monitor these side effects.
NCT ID: NCT07535541 Title: A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007) Status: RECRUITING Phase: NA Sponsor: University of Virginia Start date: 2026-05-01 URL: https://clinicaltrials.gov/study/NCT07535541 Source: UniteRare clinical trials database